Latest news


PCI Biotech initiates research collaboration with IMV Inc

Posted on May 24, 2018

Exploring synergies between PCI and DPX technologies to further enhance the effect of novel oncologic therapies Oslo (Norway) 24 May 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that it is initiating a preclinical research collaboration with IMV Inc (TSE:IMV) (OTCQX:IMMVD) Nova Scotia (Canada), a clinical stage biopharmaceutical corporation focused […]

PCI Biotech to present at BioEquity Europe

Posted on May 15, 2018

Oslo, Norway, May 15, 2018 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the Company at BioEquity Europe, an investor and partnering event. The event is taking place at Het Pand, Ghent, Belgium, 15-16 May 2018. Mr. Ronny Skuggedal, CFO, will present an […]

Notice of Annual General Meeting 2018

Posted on May 8, 2018

Oslo, Norway 8 May 2018 – The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 29, 10am CEST (local time). Venue: Jónas Einarsson Auditorium (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway. Please find […]